Massachusetts-based Codman Neuro is preparing to take Asia Pacific by storm with new regulatory wins in China, South Korea and Taiwan for the company’s Revive SE thrombectomy device.
Codman Neuro
Johnson & Johnson closes $480 million deal for Micrus Endovascular
Johnson & Johnson (NYSE:JNJ) closed its $480 million cash deal to acquire Micrus Endovascular Corp. (NSDQ:MEND), a San Jose, Calif.-based maker of cerebral vascular devices.
San Jose, Calif.-based Micrus specializes in “bioactive” coils used to treat ischemic stroke and aneurysms.